Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.9
-313.97%
40%
—
16.80%
40%
—
5 Years
Score2.9
Net Growth-313.97%
Net Trend40%
Net Income Consistency—
Rev Growth16.80%
Rev Trend40%
Revenue Consistency—
Myriad Genetics Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 82M to $ 824M and net income went from -$ 39M to -$ 365M. Revenue increased in 14 of those 20 years; net income in 12.
Across Myriad Genetics Inc's full reported history, from 1995 to 2025, revenue grew from $ 6M to $ 824M and net income went from -$ 5M to -$ 365M. Revenue increased in 77% of the years measured; net income in 53%.
Myriad Genetics Inc currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.23 | — |
1 Year2025-08-12 | $ 6.03 | -46.43% |
5 Years2021-08-12 | $ 33.53 | -90.37% |
10 Years2016-08-12 | $ 21.54 | -85.00% |
20 Years2006-08-11 | $ 10.88 | -70.31% |
30 Years1996-08-12 | $ 4.10 | -21.18% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 |
|---|---|---|---|---|---|---|
| Price | $ 3.23 | $ 6.03 | $ 33.53 | $ 21.54 | $ 10.88 | $ 4.10 |
| Return | — | -46.43% | -90.37% | -85.00% | -70.31% | -21.18% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 806M | -$ 112M | $ 115M |
| 2025 | $ 824M | -$ 365M | $ 149M |
| 2024 | $ 837M | -$ 127M | $ 102M |
| 2023 | $ 753M | -$ 263M | $ 140M |
| 2022 | $ 678M | -$ 112M | $ 114M |
| 2021 | $ 690M | -$ 27M | $ 339M |
| 2020 | $ 557M | -$ 223M | $ 150M |
| 2019 | $ 851M | $ 4M | $ 136M |
| 2018 | $ 772M | $ 131M | $ 180M |
| 2017 | $ 771M | $ 21M | $ 150M |
| 2016 | $ 753M | $ 125M | $ 159M |
| 2015 | $ 723M | $ 80M | $ 144M |
| 2014 | $ 778M | $ 176M | $ 270M |
| 2013 | $ 613M | $ 147M | $ 531M |
| 2012 | $ 496M | $ 112M | $ 454M |
| 2011 | $ 402M | $ 100M | $ 346M |
| 2010 | $ 362M | $ 152M | $ 403M |
| 2009 | $ 326M | $ 84M | $ 316M |
| 2008 | $ 333M | $ 47M | $ 328M |
| 2007 | $ 157M | -$ 34M | $ 308M |
| 2006 | $ 114M | -$ 38M | $ 227M |
| 2005 | $ 82M | -$ 39M | $ 113M |
| 2004 | $ 56M | -$ 40M | $ 115M |
| 2003 | $ 64M | -$ 24M | $ 72M |
| 2002 | $ 53M | -$ 13M | $ 73M |
| 2001 | $ 45M | -$ 7M | $ 127M |
| 2000 | $ 34M | -$ 8M | $ 80M |
| 1999 | $ 25M | -$ 10M | $ 9M |
| 1998 | $ 23M | -$ 9M | $ 14M |
| 1997 | $ 15M | -$ 9M | $ 15M |
| IPO1995 | $ 6M | -$ 5M | $ 13M |
Explore beyond MYGN
You're looking at Myriad Genetics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
